The world's first Platform-as-a-Service for digital biomarkers.

Most digital biomarkers stay stuck in the lab because moving to clinical use is too expensive and slow. WeGuide Biomarkers is a complete platform that handles the tech, the data, and the regulatory hurdles, so you can turn your research into a tool doctors can actually use.

By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.

Thank you! Your submission has been received!

Oops! Something went wrong. Please try again.

10x

Cost Reduction

Skip the high cost and risk of building from scratch.

12%

Faster validation

Move from a raw idea to a clinical tool in weeks, not years.

Class IIb

TGA ready

Skip the regulatory headache with a platform built for medicalgrade apps.

13485

ISO compliant

Your data is protected by global standards for safety and quality.

Complete infrastructure from data collection to clinical distribution

Design your study

Set up your study in minutes. Our no code builder lets you define exactly which data points to track without needing a software team.

Participant engagement

Collect rich data through a single, white labelled app. From smartwatches to video tasks, we make it easy for participants to stay involved.

AI-poweered studio

Automate the heavy lifting. Use our proprietary tools to clean your data and test hundreds of algorithm variants at once.

Commercial ready

Once validated, distribute your biomarker to clinicians or pharma partners through our secure API and payment gateway.

Digital biomarkers?

Simple tools for a complex world

A digital biomarker is just a way of using technology like a smartwatch or a mobile app to track a person's health in their own home. Instead of a patient coming into a clinic once every six months, you can see how they are actually doing every single day.

It is about moving from a "guess" to "data." Whether it is tracking how someone walks after a stroke or monitoring heart rate during a trial, digital biomarkers give you a clear, continuous picture of a patient’s recovery.

Learn More

Why digital biomarkers are so hard to build

It costs a fortune

Developing a single digital biomarker from scratch averages around $3.8M USD. Most teams simply don't have the budget to build their own custom setup.

Patients are left waiting

Traditional clinical trials and hospital studies have wait times of 6 to 9 months. Patients miss out on better care while researchers struggle with manual tech.

Data is a mess

Getting information from a Garmin watch to talk to a pathology report is a massive technical headache. Researchers spend more time cleaning data than doing science.

The regulatory wall

Moving from a research script to something the TGA approves for medical use is where most projects fail. Without a clear path to approval, the work often stalls.

Everything you need for
Support Employee Wellbeing

See how the platform works

It is much easier to understand the power of the platform when you see it. Watch how we bring different types of data together to help you build and check your biomarkers in one simple setup.

Your 4-step path to a validated biomarker

Design Your Study

Use our simple builder to define your data points, triggers, and milestones. Whether you are tracking gait, heart rate, or patient-reported outcomes, you can set up your entire protocol from home without needing a software team.

Collect rich data

Gather high-frequency data seamlessly through a single app. WeGuide connects with Apple Health, Garmin, and medical sensors so participants can share their info easily.

Validate and deploy

Use our AI-powered studio to clean your data and test different math variants automatically. Once your biomarker is validated, our platform handles the distribution to hospitals or pharma partners through a secure API with built-in payments.

Patient engagement

Build and maintain a patient community with News, Education, and Symptom Tracking.

Learn more

Helping researchers transform ideas into
discoveries.

Hear what our clients have to say!

"WeGuide has transformed how we engage with our community. The platform made it simple to launch our air quality monitoring study across 15 neighborhoods in just three weeks."

Susan Clifford

Senior Research Officer

“The multilingual support was game-changing. We reached citizens who were previously excluded from research opportunities, resulting in a truly representative dataset.”

Kaya Gardiner

Trial Project Manager

"WeGuide has transformed how we manage our patient registry. The ease of digital screening and obtaining eConsent has significantly improved our workflow."

Emma Weatherley

Managing Director

"The WeGuide trial offers staff a practical tool for recording daily COVID-19 symptoms and temperatures. For those in high-risk areas, daily reminders and alerts provide peace of mind and reassurance about their health."

Kate Cranwell

Manager

"It’s obvious that WeGuide is committed to develop technology that benefits people in the community. WeGuide has been a great partner in achieving this goal within Western Health."

Paul Eleftheriou

Chief Medical Officer

Frequently asked questions about digital biomarkers

Common questions about digital biomarkers

How is this different from a custom-built app?

A custom build is a one-off project that is hard to maintain and update. WeGuide is a scalable platform, meaning you get all the benefits of our ongoing security updates and regulatory work without the $3M price tag.

Can I use my own AI models?

Yes. Our studio is a sandbox where you can implement your own logic. We provide the tools to help you refine and validate those models against clinical gold standards.

Is the platform secure?

Security is our priority. We are Australian-owned and operated, and our infrastructure is fully compliant with the Privacy Act and international standards like ISO 27001.

Do you support regional and remote research?

Absolutely. By moving testing from the clinic to the home (BYOD), you can reach participants anywhere in Australia from the middle of Sydney to regional WA.

How does the royalty model work?

When you commercialise a biomarker through our marketplace, WeGuide takes a 30% royalty to cover the ongoing regulatory and hosting costs, while you keep the majority of the revenue.

What biomarkers are already on the platform?

We are currently working on biomarkers for mobility recovery, women's health, and more. Our partnership with NeuRA is the first of many validated tools available for distribution.

Never miss an update

Get all the latest news, blog posts and product updates from WeGuide, delivered directly to your inbox. We'll rarely send more than one email a month.

By clicking Organise a demo, you're confirming that we can contact you to set up a demonstration.

Thank you! Your submission has been received!

Oops! Something went wrong. Please try again.